China Life Insurance Posts Record 2025 Earnings and Expands Role in China’s Policy Priorities

An update from China Life Insurance Co ( (HK:2628) ) is now available.

China Life Insurance reported record results for 2025, the final year of China’s 14th Five-Year Plan, with total assets rising to RMB7.59 trillion and net assets up 16.7% to RMB608.39 billion, underscoring strengthened capital position and industry-leading embedded value. Gross written premiums climbed to RMB729.89 billion, new business value surged 35.7%, and net profit attributable to shareholders jumped 44.1% to RMB154.08 billion, supporting a higher total cash dividend of RMB8.56 per 10 shares.

The insurer reinforced its top-tier market standing, ranking first globally by life and health reserves, maintaining the highest asset-liability management rating, and winning multiple industry awards. Strategically, it deepened support for national priorities by expanding inclusive and pension insurance, backing rural revitalisation, and directing substantial long-term insurance funds into key sectors and China’s capital markets, while advancing ESG performance to an MSCI AA rating.

The most recent analyst rating on (HK:2628) stock is a Buy with a HK$40.00 price target. To see the full list of analyst forecasts on China Life Insurance Co stock, see the HK:2628 Stock Forecast page.

More about China Life Insurance Co

China Life Insurance Company Limited is a leading life insurer in the People’s Republic of China, focusing on life, health, pension and annuity products. The company plays a key role in China’s multi-tiered social security system and inclusive insurance, with a strong presence in pension and commercial annuity insurance, including third-pillar private pension offerings.

Average Trading Volume: 67,322,272

Technical Sentiment Signal: Buy

Current Market Cap: HK$1130.1B

For detailed information about 2628 stock, go to TipRanks’ Stock Analysis page.